, /PRNewswire-USNewswire/ -- Cayenne Medical, Inc., a privately held sports medicine device company dedicated to solving problems in soft tissue repair, announced the launch of their latest platform technology, BioWick™. The company's first solution utilizing the BioWick technology is designed to address the biology issue associated with rotator cuff repair failures.
The BioWick™ SureLock™ Implant, an interpositional scaffold wick, is deployed arthroscopically between tendon and bone, allowing surgeons to maintain their current standard technique while reducing bone removal through a smaller pilot hole. The implant will be debuted at the 2016 American Academy of Orthopaedic Surgeons Annual Meeting (AAOS), , at booth #2809.
About Cayenne Medical, Inc.
Cayenne Medical designs, develops and markets technically advanced soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005, the company continues to lead the transformation of traditional arthroscopic procedures by applying innovative technology through minimally invasive techniques to restore native anatomy.
Cayenne Medical Product Lines
The complete sports medicine offering of knee products includes: AperFix®, the only soft tissue multi-ligament system with rigid aperture fixation, CrossFix®, an all-suture meniscal repair device, and iFix®, for bone-tendon bone fixation. Cayenne Medical also offers the Quattro® and SureLock™ Systems including shoulder products for rotator cuff repair, labral repair, biceps tenodesis, and beyond. The company recently expanded its product portfolio to include the Mirror™ Partial Knee System, incorporating proprietary technology that uniquely tensions the ligaments to balance the knee throughout the entire range of motion.
Cayenne Medical, Inc.